ArticleCancer research2022

CIC-Mediated Modulation of MAPK Signaling Opposes Receptor Tyrosine Kinase Inhibitor Response in Kinase-Addicted Sarcoma.

Igor Odintsov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.